文献速递细菌感染、耐药与抗菌药物医院感染防控

不同分母定义对标准化抗生素消耗率测算的影响:对 antimicrobial stewardship 项目的意义

Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

本研究在两个系统医院(894张床位的学术中心和114张床位的社区医院)比较住院日(DP)、患者日(PD)、在场人数(PP)和计费日(BD)四种高危分母定义对哌拉西林/他唑巴坦、阿米卡星、达托霉素和万古霉素标准化消耗率(SCR)的影响。结果显示DP与PP定义下SCR高度一致(学术中心R2=0.99,社区医院R2=0.99),而使用替代分母时哌拉西林/他唑巴坦SCR在机构层面被高估28%-93%。作者认为数据来源和分母定义会实质性影响抗生素SCR,中心在设定消耗基准和内部评估时应仔细考虑这些变异来源。

要点

  • DP与PP定义下四药SCR高度一致(两中心R2均为0.99)
  • 使用替代分母时哌拉西林/他唑巴坦SCR被高估28%-93%
  • 数据来源和分母定义会实质性影响抗生素SCR

核心结论

  • 数据来源和高危分母天数的定义会实质性影响抗生素标准化消耗率,中心在设定消耗基准和内部评估使用时应仔细考虑这些潜在变异来源。

研究设计与样本

  • 数据来自两个系统医院:一个894张床位的学术中心和一个114张床位的社区医院。
  • 从电子数据库提取机构层面的住院抗生素给药和占用数据,占用数据来自入院-出院-转院系统。
  • 高危天数定义为住院日(DP)、患者日(PD)、在场人数(PP)和计费日(BD),用四种主要抗菌药物的住院治疗天数(DOT)按各分母计算机构层面SCR,并以最小二乘回归和R2值评估。

主要发现

  • 894张床位学术医院中,机构层面月均天数按DP、PP、PD、BD定义分别为28 424、22 198、15 957和14 789。
  • 114张床位社区医院中,机构层面月均天数按DP、PP、PD定义分别为5175、3523和2816。
  • 两中心四种住院抗生素的机构层面SCR在DP与PP定义间均呈高度一致性:学术中心R2=0.99(y=0.78x-0.001),社区医院R2=0.99(y=0.68x-0.03)。
  • 在哌拉西林/他唑巴坦SCR分析中,使用替代分母时各中心机构层面速率被高估28%-93%。

临床怎么用

  • 作者认为中心在设定消耗基准和内部评估使用时,应仔细考虑数据来源和分母定义带来的潜在变异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To quantify the impact of varying the at-risk days definition on the overall report of at-risk days and on the calculated standardized consumption rates (SCRs) for piperacillin/tazobactam, amikacin, daptomycin and vancomycin. METHODS: Data were evaluated for two system hospitals, an 894 bed academic centre and a 114 bed community hospital. Aggregate inpatient antibiotic administration and occupancy data were extracted from electronic databases at the facility-wide level. Occupancy data were reported from admission-discharge-transfer systems. At-risk days were defined as hospital days present (DP), patient days (PD), persons present (PP) and billing days (BD). Inpatient antimicrobial days of therapy (DOT) across four major antimicrobial agents were used to calculate facility-wide SCRs using each denominator and were evaluated by least-squares regression and R2 values. RESULTS: Within the 894 bed academic hospital, the average monthly facility-wide days were 28 424, 22 198, 15 957 and 14 789 by the DP, PP, PD and BD definitions, respectively. Within the 114 bed community hospital, the average monthly facility-wide days were 5175, 3523 and 2816 by the DP, PP and PD definitions, respectively. Strong concordance was observed between facility-wide SCRs using the DP and PP definitions in both the academic (R2 = 0.99, y = 0.78x - 0.001) and community (R2 = 0.99, y = 0.68x - 0.03) centres across all four inpatient antibiotics evaluated. In an analysis of piperacillin/tazobactam SCRs, rates were over-predicted by 28%-93% at the facility-wide level across centres using alternative denominators. CONCLUSIONS: We found that data source and definitions of at-risk denominator days meaningfully impact antibiotic SCRs. Centres should carefully consider these potential sources of variation when setting consumption benchmarks and internally evaluating use.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Avedissian SN, Scheetz MH, Zembower TR, et al. Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2018. PMID: 30085084. doi:10.1093/jac/dky275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。